Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer
Open Access
- 20 February 2021
- journal article
- research article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 5 (4), 567-574
- https://doi.org/10.1002/ags3.12447
Abstract
Background Pancreatic cancer is one of the most aggressive digestive cancers. The tumor expression of thrombomodulin (TM) is correlated with favorable prognosis in several types of cancer. However, this correlation has not been confirmed in hepato‐pancreato‐biliary cancer. The aim of this study was to evaluate the prognostic value of TM expression in resected pancreatic ductal adenocarcinoma. Methods The data of patients who underwent pancreatic resection for pancreatic invasive ductal adenocarcinoma were obtained from a prospectively maintained database. A total of 131 patients were included. Paraffin sections of tumor tissues were stained immunohistochemically using TM antibody. The patients were divided into two groups: the TM‐positive or TM‐negative group. Results The specimens were TM‐positive in 72 cases. TM expression was a significant factor of favorable prognosis in univariate analysis for disease‐free (DFS) and overall survival (OS). The median OS in the TM‐positive patients was 32.9 mo, which was better than the 20.0 mo in TM‐negative patients (P =.006). TM positivity retained its significance on multivariate analysis for DFS (hazard ratio [HR] 0.651, 95% confidence interval [CI] 0.433–0.979, P =.039) and OS (HR 0.569, 95% CI 0.376–0.862, P =.008). Conclusions The tumor expression of TM is a favorable factor for OS in resected pancreatic invasive ductal adenocarcinoma.Keywords
This publication has 34 references indexed in Scilit:
- The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigenBlood, 2012
- Downregulation of Thrombomodulin, a Novel Target of Snail, Induces Tumorigenesis through Epithelial-Mesenchymal TransitionMolecular and Cellular Biology, 2010
- The Role of Thrombomodulin in MalignancySeminars in Thrombosis and Hemostasis, 2007
- Thrombomodulin expression in colorectal carcinoma is protective and correlates with survivalBritish Journal of Cancer, 2006
- Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.JCI Insight, 1998
- An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potentialJournal of Oral Pathology & Medicine, 1997
- The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomasCancer Letters, 1995
- Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinomaHepatology, 1995
- Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.JCI Insight, 1991
- Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.Proceedings of the National Academy of Sciences of the United States of America, 1981